ANDELYN BIOSCIENCES
LIVE

Serial Number

97288838

Owner

Andelyn Biosciences, Inc.

Attorney

Ajay A. Jagtiani

First Use Date

Aug 12, 2020

Filing Date

Mar 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ANDELYN BIOSCIENCES Trademark

Serial Number: 97288838 • Registration: 7083888

ANDELYN BIOSCIENCES is a trademark filed by Andelyn Biosciences, Inc. on March 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Andelyn Biosciences, Inc. (14 trademarks)

1180 Arthur E. Adams Dr.
Columbus, OH 43221

Entity Type: 03

Trademark Details

Filing Date

March 1, 2022

Registration Date

June 20, 2023

First Use Anywhere

August 12, 2020

First Use in Commerce

August 12, 2020

Published for Opposition

April 4, 2023

Goods & Services

Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents

Pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products for use in the treatment of genetic diseases and disorders

Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 21, 2025 ASCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 8, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 8, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 8, 2023 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 20, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 20, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 28, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 28, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 28, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 28, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 13, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 5, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2022 NWOS
NEW APPLICATION ENTERED
Mar 4, 2022 NWAP